[
  {
    "ts": null,
    "headline": "Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday",
    "summary": "Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe.  The CE mark is an affirmation by a product's manufacturer that it conforms with a range of standards covering aspects such as health and safety.  In its press release touting the development, Abbott wrote that roughly 8 million people in Europe over the age of 65 are coping with atrial fibrillation, and that figure is anticipated to double within three decades.",
    "url": "https://finnhub.io/api/news?id=cdd3bf04709cd2c2a9cc6467c744e9e6be7ebbdd3ae23a3e62a5dffecc8cfb87",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743116088,
      "headline": "Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday",
      "id": 133505702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe.  The CE mark is an affirmation by a product's manufacturer that it conforms with a range of standards covering aspects such as health and safety.  In its press release touting the development, Abbott wrote that roughly 8 million people in Europe over the age of 65 are coping with atrial fibrillation, and that figure is anticipated to double within three decades.",
      "url": "https://finnhub.io/api/news?id=cdd3bf04709cd2c2a9cc6467c744e9e6be7ebbdd3ae23a3e62a5dffecc8cfb87"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: GM Stock Tumbles After Trump Declares Auto Tariffs",
    "summary": "The S&P 500 declined 0.3% on Thursday, March 27, after the White House announced a 25% tariff on auto imports will take effect next week.",
    "url": "https://finnhub.io/api/news?id=543bf5fed603e9078fbbfbd28e1e4e9a5b2a2ab0d25736830ff5d12477421204",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743108663,
      "headline": "S&P 500 Gains and Losses Today: GM Stock Tumbles After Trump Declares Auto Tariffs",
      "id": 133505703,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The S&P 500 declined 0.3% on Thursday, March 27, after the White House announced a 25% tariff on auto imports will take effect next week.",
      "url": "https://finnhub.io/api/news?id=543bf5fed603e9078fbbfbd28e1e4e9a5b2a2ab0d25736830ff5d12477421204"
    }
  },
  {
    "ts": null,
    "headline": "Equity Markets On Track to Close Lower Following Trump's Auto Tariffs",
    "summary": "US benchmark equity indexes are on track to close lower on Thursday, as markets weigh the impact of",
    "url": "https://finnhub.io/api/news?id=e321cf87da2ea2c3d95f7144c372697be216534d84c9606cb0782c6ac258d7eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743104971,
      "headline": "Equity Markets On Track to Close Lower Following Trump's Auto Tariffs",
      "id": 133485491,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes are on track to close lower on Thursday, as markets weigh the impact of",
      "url": "https://finnhub.io/api/news?id=e321cf87da2ea2c3d95f7144c372697be216534d84c9606cb0782c6ac258d7eb"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=177f8d48e8e8de33328a960a4840e44f127710045afaf3706e0bc5be07e732af",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743093000,
      "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "id": 133487186,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=177f8d48e8e8de33328a960a4840e44f127710045afaf3706e0bc5be07e732af"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT): Among Dividend Zombies to Invest in",
    "summary": "We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other dividend zombies to invest in. The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing on the […]",
    "url": "https://finnhub.io/api/news?id=2fec940b5dbc33742b9d3c15040ec41d7001ebbe3f9d3bdadea8bd00cea2a369",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743083160,
      "headline": "Abbott Laboratories (ABT): Among Dividend Zombies to Invest in",
      "id": 133471709,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other dividend zombies to invest in. The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing on the […]",
      "url": "https://finnhub.io/api/news?id=2fec940b5dbc33742b9d3c15040ec41d7001ebbe3f9d3bdadea8bd00cea2a369"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms",
    "summary": "Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies. The company will further expand use of Volt in EU markets throughout the second half of the year.",
    "url": "https://finnhub.io/api/news?id=d1daf4d5110c1b21de27fae622618f8e01026d37a57904f771769dc161f1b76c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743080400,
      "headline": "Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms",
      "id": 133471711,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies. The company will further expand use of Volt in EU markets throughout the second half of the year.",
      "url": "https://finnhub.io/api/news?id=d1daf4d5110c1b21de27fae622618f8e01026d37a57904f771769dc161f1b76c"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Receives CE Mark For Its Volt(TM) Pulsed Field Ablation System To Treat Patients With Abnormal Heart Rhythms",
    "summary": "Abbott Laboratories: * ABBOTT RECEIVES CE MARK FOR ITS VOLT™ PULSED FIELDABLATIONSYSTEM TO TREAT PATIENTS WITH ABNORMAL HEART RHYTHMSSource text:Further company coverage: ...",
    "url": "https://finnhub.io/api/news?id=a00472695cefc5a378bd7d679841ad57f2c7b52d8adc8a1acfc600ee1673a82a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743066263,
      "headline": "Abbott Receives CE Mark For Its Volt(TM) Pulsed Field Ablation System To Treat Patients With Abnormal Heart Rhythms",
      "id": 133470599,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "Abbott Laboratories: * ABBOTT RECEIVES CE MARK FOR ITS VOLT™ PULSED FIELDABLATIONSYSTEM TO TREAT PATIENTS WITH ABNORMAL HEART RHYTHMSSource text:Further company coverage: ...",
      "url": "https://finnhub.io/api/news?id=a00472695cefc5a378bd7d679841ad57f2c7b52d8adc8a1acfc600ee1673a82a"
    }
  }
]